Loading...

New Competitive Pressures And Regulatory Shifts Will Shape Market Leadership

Published
08 Aug 24
Updated
25 Apr 26
Views
403
25 Apr
US$164.04
AnalystConsensusTarget's Fair Value
US$229.19
28.4% undervalued intrinsic discount
Loading
1Y
-37.4%
7D
-0.1%

Author's Valuation

US$229.1928.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 25 Apr 26

Fair value Decreased 2.91%

EFX: AI And Marketing Reset Will Support Long Term Earnings Power

Analysts trimmed the Equifax fair value estimate by about $7 to $229.19. Lower price targets from several firms, slightly higher discount rate assumptions, and a reduced revenue growth outlook were only partly balanced by a higher projected profit margin and a lower future P/E multiple.

Analyst Commentary

Recent Street research around Equifax reflects a mix of optimism on the long term business model and caution around execution risks and valuation, which is feeding into a wide range of price target revisions.

Bullish Takeaways

  • Bullish analysts highlight an overall constructive view on information and business services, with expectations for revenue, EPS, and free cash flow growth for the broader peer group by 2026. This supports the case that Equifax could participate in that growth path if it executes well.
  • Some research points to enduring EPS growth not fully reflected in the current valuation. This suggests investors may be underpaying for the earnings power that Equifax could deliver over time.
  • Commentary around the VantageScore 4.0 pricing change to $1 per score frames it more as a marketing effort than a fundamental shift. This implies that competitive pressures from this move may be less severe for Equifax economics than headlines suggest.
  • Despite recent volatility tied to Senate comments and AI related concerns, at least one major firm sees a potential Medicaid related tailwind. This could help support Equifax revenue streams connected to government and benefits related data services.

Bearish Takeaways

  • Bearish analysts have lowered price targets by meaningful amounts, including cuts of $30 or more from JPMorgan, Goldman Sachs, and others. This reflects concerns that prior expectations for growth or profitability may have been too optimistic relative to current execution and macro visibility.
  • Several firms trimming targets in close succession signals a reset of valuation frameworks, with lower assumed multiples and higher discount rates that reduce what analysts are willing to pay for Equifax earnings and cash flows.
  • Lower targets framed around AI related fears and regulatory scrutiny point to risk that new technology and policy developments could pressure parts of Equifax core scoring and data businesses or require higher investment. This would weigh on margins if not offset elsewhere.
  • The clustering of cuts across many banks on the same date suggests that Street expectations are being recalibrated together. This can limit near term support from target based buyers who rely heavily on consensus valuation anchors.

What’s in the News

  • Recent reporting links advancements in AI tools to pressure on software and data stocks, putting Equifax in focus as investors reassess how AI could affect data centric business models (Wall Street Journal).
  • Equifax issued earnings guidance for 2Q 2026, with expected revenue between US$1.680b and US$1.710b and a stated revenue growth range of 9.3% to 11.3% for the quarter.
  • The company updated 2026 full year guidance, outlining expected revenue of US$6.685b to US$6.805b, a revenue growth range of 10.0% to 12.0%, and an increase of US$25m in full year reported revenue guidance, while keeping constant dollar revenue growth guidance unchanged given interest rate and U.S. mortgage uncertainties.
  • Equifax reported ongoing capital returns, repurchasing 1,344,615 shares, or 1.12% of shares, for US$260m in 1Q 2026 and completing 5,350,788 shares, or 4.37%, for US$1,187.39m under the current buyback program.
  • New product launches tied to The Work Number and other credit data solutions, including the Work Number Record Indicator and multiple Employment Insights offerings, highlight continued product development aimed at giving lenders more detailed views of borrower income, employment, and potential fraud risk.

Valuation Changes

  • Fair value was reduced from $236.05 to $229.19, a decline of about 3% in the model estimate.
  • The discount rate increased slightly from 7.84% to 7.87%, indicating a modestly higher required return in the valuation inputs.
  • Revenue growth was trimmed from 10.08% to 9.66%, pointing to a softer top line growth outlook in the forecast period.
  • The net profit margin was raised from 15.28% to 15.45%, reflecting a small improvement in expected profitability.
  • The future P/E was lowered from 26.06x to 23.39x, suggesting a reduced valuation multiple applied to projected earnings.
5 viewsusers have viewed this narrative update

Key Takeaways

  • New product solutions, technology investments, and international expansion are driving stronger organic growth, margin improvements, and increased customer retention for Equifax.
  • Rising demand for eligibility verification and a broadening data moat are reducing business cyclicality and diversifying long-term revenue streams.
  • Rising litigation, regulatory, and competitive pressures may constrain Equifax's revenue growth, compress profit margins, and increase volatility in key business segments.

Catalysts

About Equifax
    Operates as a data, analytics, and technology company.
What are the underlying business or industry changes driving this perspective?
  • Accelerating customer adoption of new multi-data product solutions (e.g., TWN indicator, Single Data Fabric, EFX.AI) and continued high NPI (New Product Introduction) rates are expanding Equifax's value proposition, positioning the company to capture incremental market share and drive sustained organic revenue growth above historical levels.
  • Structural expansion of government verification requirements (e.g., semiannual redeterminations, added work requirements, improper payment focus) and a rising TAM for eligibility verification services are set to benefit long-term revenue growth and reduce business cyclicality as Equifax's solutions become more critical to federal and state programs.
  • Rapidly growing Work Number record base and increased penetration with employers and states are broadening Equifax's data moat, supporting future product launches and increasing customer stickiness, which should underpin both topline growth and resilient high margins.
  • Global cloud migration and investments in proprietary technology platforms are now largely complete, enabling margin expansion through operating leverage, efficiency gains, and scalable innovation, which is expected to increase EBITDA and net margins over time.
  • International expansion, especially in underpenetrated markets like Latin America and through the integration of new platforms (Ignite, InterConnect, Data Fabric), is diversifying Equifax's revenue streams and providing additional runway for earnings growth and margin improvement.
Equifax Earnings and Revenue Growth

Equifax Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Equifax's revenue will grow by 9.7% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 11.1% today to 15.4% in 3 years time.
  • Analysts expect earnings to reach $1.3 billion (and earnings per share of $11.31) by about April 2029, up from $698.7 million today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 23.6x on those 2029 earnings, down from 29.4x today. This future PE is greater than the current PE for the US Professional Services industry at 18.9x.
  • Analysts expect the number of shares outstanding to decline by 4.13% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.87%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Ongoing litigation costs and elevated small claims volumes are driving up corporate expenses, with Equifax expecting these legal costs to remain high in the near-to-medium term, exerting downward pressure on net margins and potentially limiting earnings growth.
  • Persistent budget constraints at the U.S. state level, resulting from changes in federal reimbursement policy, have increased revenue volatility in the government segment; this makes Equifax's medium-term government revenue growth less predictable, with delayed contracts and program adoption potentially suppressing revenue relative to long-term targets.
  • The evolving competitive landscape-including increased adoption of alternative credit scoring models, the rising prominence of fintechs, and possible price competition linked to VantageScore-could erode Equifax's market share and pricing power, especially in traditional mortgage and lending segments, potentially reducing future revenue growth and net margins.
  • Heightened macroeconomic uncertainty (e.g., inflation, tariffs, weak hiring/white-collar employment, and volatile mortgage markets) creates risk of weaker-than-expected demand in major revenue drivers like hiring, lending, and auto/credit card origination-leading to softer-than-anticipated revenue and earnings over the long term.
  • Growing regulatory focus on data privacy, combined with increased consumer litigation and reputational risk from historical data breaches, may further increase compliance costs, compress margins, and limit Equifax's ability to fully monetize its data assets, threatening long-term revenue expansion and profitability.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $229.19 for Equifax based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $270.0, and the most bearish reporting a price target of just $195.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $8.3 billion, earnings will come to $1.3 billion, and it would be trading on a PE ratio of 23.6x, assuming you use a discount rate of 7.9%.
  • Given the current share price of $172.47, the analyst price target of $229.19 is 24.7% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Equifax?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives